Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
This study is a two-arm, multicenter, randomized controlled clinical trial on whether single-port extraperitoneal VIP RARP is non-inferior to multi-port transperitoneal RARP in terms of functional recovery rate and other key metrics.
• Men aged 18 years ≤ age ≤ 75 years;
• Prostate biopsy within 6 months with diagnosis of organ-localized prostate cancer with preoperative staging of T1c to T2b,N0M0;.
• Gleason Score\<8.
• PSA\<20ng/ml.
• Pathologic diagnosis of prostate follicular adenocarcinoma or prostate ductal adenocarcinoma;
• The patient has healthy sexual function before surgery and intention for sexual activities after surgery;
• Physiological condition acceptable for laparoscopic surgery;
• Willing to cooperate and complete the study follow-up and related examinations;
• The subject or his agent voluntarily participates in this trial and signs the written informed consent;
⁃ The questionnaire can be completed in Chinese.
⁃ The patient has been informed of the trial;